This positive correlation between BRG1 expression and tissue malignancy was in agreement with the results of gastric cancer (Sentani et al, 2001), prostate cancer (Sun et al, 2007) and cutaneous melanoma (Lin et al, 2010) but not with those of lung cancer (Reisman et al, 2003). The gene discussed is SMARCA4; the disease is prostate cancer.